Jonas Söderholm

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE. 2021;8:20499361211053929-204993612110539

Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway.

Hannula R; Söderholm J; Svendsen T; Skaland M; Nordbø SA; Steinum H; Damås JK
Article: BMJ OPEN. 2020;10(9):e035996

Sick leave and disability pension in patients with chronic hepatitis C compared with a matched general population: a nationwide register study.

Büsch K; Hansson F; Holton M; Lagging M; Westin J; Kövamees J; Sällberg M; Söderholm J
Article: LIVER INTERNATIONAL. 2020;40(8):1832-1840

Frequent loss to follow-up after diagnosis of hepatitis C virus infection: A barrier towards the elimination of hepatitis C virus.

Aleman S; Söderholm J; Büsch K; Kövamees J; Duberg A-S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(5):574-580

High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder.

Kåberg M; Larsson SB; Jerkeman A; Nystedt A; Duberg A-S; Kövamees J; Ydreborg M; Aleman S; Büsch K; Alanko Blomé M; Weiland O; Söderholm J
Article: JOURNAL OF NEUROLOGY. 2019;266(9):2208-2215

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.

Söderholm J; Yilmaz A; Svenningsson A; Büsch K; Wejstål R; Brolund A; Kövamees J; Sällberg M; Lagging M; Gisslén M
Article: JOURNAL OF HEPATOLOGY. 2018;68(5):904-911

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.

Söderholm J; Millbourn C; Büsch K; Kövamees J; Schvarcz R; Lindahl K; Bruchfeld A
Article: PLOS ONE. 2018;13(5):e0198296

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.

Vasanthakumar A; Davis JW; Abunimeh M; Söderholm J; Zha J; Dumas EO; Cohen DE; Waring JF; Lagging M
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2017;52(1):61-68

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

Büsch K; Waldenström J; Lagging M; Aleman S; Weiland O; Kövamees J; Duberg A-S; Söderholm J
Article: PLOS ONE. 2013;8(2):e56991

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.

Söderholm J; Waldenström J; Askarieh G; Pilli M; Bochud P-Y; Negro F; Pawlotsky J-M; Zeuzem S; Ferrari C; Norkrans G; Wejstål R; Westin J; Neumann AU; Haagmans BL; Lindh M; Missale G; Hellstrand K; Lagging M
Article: VACCINE. 2012;30(48):6946-6954

Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.

Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
Article: JOURNAL OF GENERAL VIROLOGY. 2012;93(Pt 8):1680-1686

Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease.

Ahlén G; Chen A; Roe B; Falkeborn T; Frelin L; Hall WW; Sällberg M; Söderholm J
Article: GUT. 2012;61(4):589-596

Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production.

Brenndörfer ED; Brass A; Söderholm J; Frelin L; Aleman S; Bode JG; Sällberg M
Article: JOURNAL OF VIRAL HEPATITIS. 2011;18(7):e325-e331

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

Lindh M; Lagging M; Arnholm B; Eilard A; Nilsson S; Norkrans G; Söderholm J; Wahlberg T; Wejstål R; Westin J; Hellstrand K
Article: JOURNAL OF IMMUNOLOGY. 2011;186(9):5107-5118

Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.

Chen A; Ahlén G; Brenndörfer ED; Brass A; Holmström F; Chen M; Söderholm J; Milich DR; Frelin L; Sällberg M
Article: GENE THERAPY. 2011;18(3):258-265

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

Broderick KE; Shen X; Soderholm J; Lin F; McCoy J; Khan AS; Yan J; Morrow MP; Patel A; Kobinger GP; Kemmerrer S; Weiner DB; Sardesai NY
Article: PLOS ONE. 2011;6(2):e17232

Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.

Lagging M; Askarieh G; Negro F; Bibert S; Söderholm J; Westin J; Lindh M; Romero A; Missale G; Ferrari C; Neumann AU; Pawlotsky J-M; Haagmans BL; Zeuzem S; Bochud P-Y; Hellstrand K; DITTO-HCV Study Group
Article: JOURNAL OF VIROLOGY. 2011;85(3):1370-1383

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Luke JM; Simon GG; Söderholm J; Errett JS; August JT; Gale M; Hodgson CP; Williams JA
Article: GENE THERAPY. 2010;17(6):811-814

Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine.

Gill HS; Söderholm J; Prausnitz MR; Sällberg M
Article: HEPATOLOGY. 2010;51(5):1523-1530

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C.

Askarieh G; Alsiö A; Pugnale P; Negro F; Ferrari C; Neumann AU; Pawlotsky J-M; Schalm SW; Zeuzem S; Norkrans G; Westin J; Söderholm J; Hellstrand K; Lagging M; DITTO-HCV and NORDynamIC Study Groups
Article: JOURNAL OF IMMUNOLOGY. 2007;179(7):4741-4753

In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells.

Ahlén G; Söderholm J; Tjelle T; Kjeken R; Frelin L; Höglund U; Blomberg P; Fons M; Mathiesen I; Sällberg M
Article: JOURNAL OF INFECTIOUS DISEASES. 2006;194(12):1724-1728

A complete mutational fitness map of the hepatitis C virus nonstructural 3 protease: relation to recognition by cytotoxic T lymphocytes.

Soderholm J; Sallberg M
Article: GUT. 2006;55(2):266-274

Relation between viral fitness and immune escape within the hepatitis C virus protease.

Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Article: GENE THERAPY. 2003;10(8):686-699

Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo.

Frelin L; Alheim M; Chen A; Söderholm J; Rozell B; Barnfield C; Liljeström P; Sällberg M
Visa fler

Alla övriga publikationer

Corrigendum: HEPATOLOGY. 2016;64(6):2278-2279

Poster Session II (Abstracts 730-1194) (vol 64, pg 361A, 2016)

Soderholm J; Millbourn C; Busch K; Kovamees J; Schvarcz R; Lindahl K; Bruchfeld A
Review: EXPERT REVIEW OF HEMATOLOGY. 2010;3(4):381-391

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.

Martner A; Thorén FB; Aurelius J; Söderholm J; Brune M; Hellstrand K

Anställningar

Anknuten till Undervisning/Handledning, Laboratoriemedicin, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, mikrobiologi, Karolinska Institutet, 2021
MEDICINE DOKTORSEXAMEN, Institutionen för laboratoriemedicin, Karolinska Institutet, 2006

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI